These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. IgG subclass changes in response to desensitisation. Nakagawa T Monogr Allergy; 1986; 19():253-61. PubMed ID: 3762551 [No Abstract] [Full Text] [Related]
28. [Desensitization immunotherapy on patients with mite-positive bronchial asthma using purified mite feces antigen fractions]. Asaoku Y; Jyo T; Mochiduki N; Kodomari Y; Kuwabara M; Yoshizane T; Shigeta S; Ono K; Tsuboi S; Ootsuka T Arerugi; 1995 Jul; 44(7):692-700. PubMed ID: 7575135 [TBL] [Abstract][Full Text] [Related]
29. [IgE, IgG1 and IgG4 antibodies against bodily and fecal extracts of Dermatophagoides farinae]. Yasumatsu Y Arerugi; 1993 Jun; 42(6):728-37. PubMed ID: 8347091 [TBL] [Abstract][Full Text] [Related]
30. The importance of IgE antibody levels in anti-IgE treatment. Johansson SG; Oman H; Nopp A; Pettersson S Allergy; 2006 Oct; 61(10):1216-9. PubMed ID: 16942572 [TBL] [Abstract][Full Text] [Related]
31. [Seasonal changes of specific IgE antibody and asthmatic attacks in patients hypersensitive to Dermatophagoides pteronyssinus (author's transl)]. Furlan-Hrabar J; Bohinjec M Plucne Bolesti Tuberk; 1981; 33(4):245-51. PubMed ID: 7345445 [No Abstract] [Full Text] [Related]
32. Mite allergy is associated with a specific profile of IgG epitopes recognized on antigen p1 of Dermatophagoides pteronyssinus. Duchateau J; Michils A; Michel O; Baras L Clin Exp Allergy; 1997 Mar; 27(3):296-305. PubMed ID: 9088656 [TBL] [Abstract][Full Text] [Related]
33. IgE and IgG anti-house dust mite specificities in allergic disease. Hales BJ; Martin AC; Pearce LJ; Laing IA; Hayden CM; Goldblatt J; Le Souëf PN; Thomas WR J Allergy Clin Immunol; 2006 Aug; 118(2):361-7. PubMed ID: 16890759 [TBL] [Abstract][Full Text] [Related]
34. Detection of blocking antibodies after hyposensitization. Castell M; Castellote C; Barbera G Immunobiology; 1985 Feb; 169(1):30-6. PubMed ID: 3988313 [TBL] [Abstract][Full Text] [Related]
35. [The effect of intrabronchial specific immunotherapy on certain immunologic parameters in asthmatic patients with allergic to house mites]. Zietkowski Z Pol Merkur Lekarski; 1999 May; 6(35):236-8. PubMed ID: 10437389 [TBL] [Abstract][Full Text] [Related]
36. Blocking IgG antibodies after rush immunotherapy with mites. Leynadier F; Abuaf N; Halpern GM; Murrieta M; Garcia-Duarte C; Dry J Ann Allergy; 1986 Nov; 57(5):325-9. PubMed ID: 3777530 [TBL] [Abstract][Full Text] [Related]
37. [Antibody response pattern (specific IgE and IgG) of insect sting allergic patients in immunotherapy with venom preparations]. Wüthrich B; Arrendal H; Lanner A Schweiz Med Wochenschr; 1981 Nov; 111(46):1756-65. PubMed ID: 7313646 [TBL] [Abstract][Full Text] [Related]
38. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685 [TBL] [Abstract][Full Text] [Related]
39. Significant decrease of IgE antibodies after a three-year controlled study of specific immunotherapy to pollen allergens in children with allergic asthma. Cantani A; Micera M Eur Rev Med Pharmacol Sci; 2005; 9(2):103-11. PubMed ID: 15945499 [TBL] [Abstract][Full Text] [Related]
40. [IgE in the serum of children with pollinosis treated by specific desensitization]. Pinkawa E; Pyda E; Labus J Wiad Lek; 1982 May; 35(5):298-303. PubMed ID: 7113217 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]